AlphaYouIC
Insider selling
Innovative Cellular Therapeutics Holdings Ltd sold $137 of Lyell Immunopharma, Inc. (LYEL) stock
Innovative Cellular Therapeutics Holdings Ltd, 10% owner of Lyell Immunopharma, Inc. (LYEL), sold 10 shares of LYEL stock worth $137, per an SEC Form 4 filed Jul 20, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 17, 2026, 3 days before it was made public.
LYEL has moved -17.9% since the trade date, from $13.32 to $10.93 (Sep 21, 2026 close).
- Traded
- Jul 17, 2026
- Disclosed
- Jul 20, 2026
- Filing delay
- 3 days
- Price since
- -17.9%
- Role
- 10% owner
- Source
- SEC Form 4
More LYEL insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.